drugset / Trial / NCT00250965

MPAACS: Magnesium for the Prevention of Atrial Arrhythmias After Cardiac Surgery

NCT00250965

RandomizedParallel-groupTriple-blindTreatment

Summary

The objective of our research is to determine whether treatment with magnesium will reduce the incidence of atrial fibrillation in patients undergoing cardiac surgery. Several small studies of magnesium have already been conducted, but these studies were small and the results conflicting. A large, well-conducted study of magnesium treatment is required to definitively determine whether magnesium is effective in preventing this common complication after surgery. In addition, our study will include patients undergoing valvular surgery, a group previously excluded from research despite the fact that they are at increased risk of atrial fibrillation.

Timeline

Start
2004-07
Primary completion
2008-09
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Magnesium Sulfate Other / unclassified 5 g Intravenous